Citation Impact
Citing Papers
Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
2012
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Regulation of growth differentiation factor 15 expression by intracellular iron
2008 StandoutNobel
Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition
2006 StandoutNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
Cancer immunotherapy: the beginning of the end of cancer?
2016
Molecular imaging in drug development
2008 Standout
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
2005 StandoutNobel
IDH1andIDH2Mutations in Gliomas
2009 Standout
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
The biology and management of non-small cell lung cancer
2018 StandoutNature
Enhanced Antitumor Efficacy of Vasculostatin (Vstat120) Expressing Oncolytic HSV-1
2009
A Selenium Analogue of Firefly D ‐Luciferin with Red‐Shifted Bioluminescence Emission
2012 StandoutNobel
Brain cancer propagating cells: biology, genetics and targeted therapies
2009
The Hedgehog and Wnt signalling pathways in cancer
2001 StandoutNature
Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery
2012
Structure-Activity Relationships of Linear and Cyclic Peptides Containing the NGR Tumor-homing Motif
2002
Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3
2004
Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade
2002 StandoutScience
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Engineering interferons and interleukins for cancer immunotherapy
2022
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Blinded by the Light: The Growing Complexity of p53
2009 Standout
The Molecular and Genetic Basis of Neurological Tumours
2002
Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors 2 2Abbreviations: CP, cyclophosphamide; PFT, pifithrin-α or p53 inhibitor; HT, hyperthermia; HS, heat shock; HO, hypoxia; and HIF-1, hypoxia inducible factor.
2001
Gliomagenesis: genetic alterations and mouse models
2001
Targeted Molecular Therapy of GBM
2003
Malignant Gliomas in Adults
2008 Standout
Apoptosis
2002 Standout
INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas
2001
Characterization of mouse brain-specific angiogenesis inhibitor 1 (BAI1) and phytanoyl-CoA alpha-hydroxylase-associated protein 1, a novel BAI1-binding protein
2001
Brain Angiogenesis Inhibitor 1 Is Differentially Expressed in Normal Brain and Glioblastoma Independently of p53 Expression
2003
Hypoxic gene expression and metastasis
2004
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Programmed Cell Senescence during Mammalian Embryonic Development
2013 Standout
Primary brain tumours in adults
2012 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Investigating hypoxic tumor physiology through gene expression patterns
2003
The PI3K Pathway in Human Disease
2017 Standout
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Identification of human brain tumour initiating cells
2004 StandoutNature
Microglia: biology and pathology
2009
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
2012 StandoutNobel
Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1
2002
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Thrombospondins and tumor angiogenesis
2001
Vasculostatin, a proteolytic fragment of Brain Angiogenesis Inhibitor 1, is an antiangiogenic and antitumorigenic factor
2005
Spermidine/Spermine N1-Acetyltransferase-1 Binds to Hypoxia-inducible Factor-1α (HIF-1α) and RACK1 and Promotes Ubiquitination and Degradation of HIF-1α
2007 StandoutNobel
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells.
2003
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Life with Oxygen
2007 StandoutScienceNobel
Induction of medulloblastomas inp53-null mutant mice by somatic inactivation ofRbin the external granular layer cells of the cerebellum
2000
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
2011
Global gene expression of cells attached to a tissue engineering scaffold
2004 StandoutNobel
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis
2012 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins
2011 StandoutNobel
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
2004 StandoutNobel
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
In Vivo Bioluminescent Imaging (BLI): Noninvasive Visualization and Interrogation of Biological Processes in Living Animals
2010
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
PTEN and phosphatidylinositol 3'-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment.
2003
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Silatecan DB-67 is a novel DNA topoisomerase I–targeted radiation sensitizer
2005
Adhesion of immunomagnetic particles targeted to antigens and cytokine receptors on tumor cells determined by magnetophoresis
2001
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Oncolytic Viruses in Cancer Treatment
2016
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched.
2001
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Physiology of Microglia
2011 Standout
The Arf/p53 Pathway in Cancer and Aging
2008
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
2018
Works of Giulia Fulci being referenced
Depletion of Peripheral Macrophages and Brain Microglia Increases Brain Tumor Titers of Oncolytic Viruses
2007
Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor alpha.
1997
Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models
2013
Cyclophosphamide Increases Transgene Expression Mediated by an Oncolytic Adenovirus in Glioma-Bearing Mice Monitored by Bioluminescence Imaging
2006
p53 and the CNS
1999
Establishing the Lysine-rich Protein CEST Reporter Gene as a CEST MR Imaging Detector for Oncolytic Virotherapy
2015
The status of gene therapy for brain tumors
2007
Restoration of endogenous wild-type p53 activity in a glioblastoma cell line with intrinsic temperature-sensitive p53 induces growth arrest but not apoptosis
2001
Effect of Tumor Microenvironment Modulation on the Efficacy of Oncolytic Virus Therapy
2007
p53 and Brain Tumors: From Gene Mutations to Gene Therapy
1998
p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma
2000
Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
2002
Thrombospondin-1 Is Downregulated by Anoxia and Suppresses Tumorigenicity of Human Glioblastoma Cells
2000
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
2006